2023-09-28 14:46:10 +00:00
|
|
|
abstract: 'Introduction: HIV and cervical cancer are intersecting epidemics that
|
|
|
|
|
|
|
|
disproportionately affect one of the most vulnerable populations in the
|
|
|
|
|
|
|
|
world: women in low-and middle-income countries (LMICs). Historically,
|
|
|
|
|
|
|
|
the disparity in cervical cancer risk for women in LMICs has been due to
|
|
|
|
|
|
|
|
the lack of organized screening and prevention programmes. In recent
|
|
|
|
|
|
|
|
years, this risk has been augmented by the severity of the HIV epidemic
|
|
|
|
|
|
|
|
in LMICs. HIV-positive women are at increased risk for developing
|
|
|
|
|
|
|
|
cervical precancer and cancer, and while the introduction of
|
|
|
|
|
|
|
|
antiretroviral therapy has dramatically improved life expectancies among
|
|
|
|
|
|
|
|
HIV-positive women it has not been shown to improve cancer-related
|
|
|
|
|
|
|
|
outcomes. Therefore, an increasing number of HIV-positive women are
|
|
|
|
|
|
|
|
living in LMICs with limited or no access to cervical cancer screening
|
|
|
|
|
|
|
|
programmes. In this commentary, we describe the gaps in cervical cancer
|
|
|
|
|
|
|
|
prevention, the state of evidence for integrating cervical cancer
|
|
|
|
|
|
|
|
prevention into HIV programmes and future directions for programme
|
|
|
|
|
|
|
|
implementation and research.
|
|
|
|
|
|
|
|
Discussion: Despite the biologic, behavioural and demographic overlap
|
|
|
|
|
|
|
|
between HIV and cervical cancer, cervical cancer prevention has for the
|
|
|
|
|
|
|
|
most part been left out of sexual and reproductive health (SRH) services
|
|
|
|
|
|
|
|
for HIV-positive women. Lower cost primary and secondary prevention
|
|
|
|
|
|
|
|
strategies for cervical cancer are becoming more widely available in
|
|
|
|
|
|
|
|
LMICs, with increasing evidence for their efficacy and
|
|
|
|
|
|
|
|
cost-effectiveness. Going forward, cervical cancer prevention must be
|
|
|
|
|
|
|
|
considered a part of the essential package of SRH services for
|
|
|
|
|
|
|
|
HIV-positive women. Effective cervical cancer prevention programmes will
|
|
|
|
|
|
|
|
require a coordinated response from international policymakers and
|
|
|
|
|
|
|
|
funders, national governments and community leaders. Leveraging the
|
|
|
|
|
|
|
|
improvements in healthcare infrastructure created by the response to the
|
|
|
|
|
|
|
|
global HIV epidemic through integration of services may be an effective
|
|
|
|
|
|
|
|
way to make an impact to prevent cervical cancer among HIV-positive
|
|
|
|
|
|
|
|
women, but more work remains to determine optimal approaches.
|
|
|
|
|
|
|
|
Conclusions: Cervical cancer prevention is an essential part of
|
|
|
|
|
|
|
|
comprehensive HIV care. In order to ensure maximal impact and
|
|
|
|
|
|
|
|
cost-effectiveness, implementation strategies for screening programmes
|
|
|
|
|
|
|
|
must be adapted and rigorously evaluated through a framework that
|
|
|
|
|
|
|
|
includes equal participation with policymakers, programme planners and
|
|
|
|
|
|
|
|
key stakeholders in the target communities.'
|
|
|
|
affiliation: 'Huchko, MJ (Corresponding Author), Mission Hall,550 16th St,Box 1224,
|
|
|
|
San Francisco, CA 94158 USA.
|
|
|
|
|
|
|
|
Huchko, Megan J.; Cohen, Craig R., Univ Calif San Francisco, Dept Obstet Gynecol
|
|
|
|
\& Reprod Sci, San Francisco, CA 94143 USA.
|
|
|
|
|
|
|
|
Maloba, May, Kenya Govt Med Res Ctr, Family AIDS Care \& Educ Serv, Kisumu, Kenya.
|
|
|
|
|
|
|
|
Nakalembe, Miriam, Makerere Univ, Dept Obstet \& Gynaecol, Kampala, Uganda.
|
|
|
|
|
|
|
|
Nakalembe, Miriam, Makerere Univ, Infect Dis Inst, Kampala, Uganda.'
|
|
|
|
author: Huchko, Megan J. and Maloba, May and Nakalembe, Miriam and Cohen, Craig R.
|
|
|
|
author-email: megan.huchko@ucsf.edu
|
|
|
|
author_list:
|
|
|
|
- family: Huchko
|
|
|
|
given: Megan J.
|
|
|
|
- family: Maloba
|
|
|
|
given: May
|
|
|
|
- family: Nakalembe
|
|
|
|
given: Miriam
|
|
|
|
- family: Cohen
|
|
|
|
given: Craig R.
|
|
|
|
da: '2023-09-28'
|
|
|
|
doi: 10.7448/IAS.18.6.20282
|
|
|
|
eissn: 1758-2652
|
|
|
|
files: []
|
|
|
|
journal: JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
|
|
|
|
keywords: 'cervical cancer prevention; HIV; integration; low- and middle-income
|
|
|
|
|
|
|
|
countries'
|
|
|
|
keywords-plus: 'RANDOMIZED CONTROLLED-TRIAL; SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY;
|
|
|
|
|
|
|
|
COST-EFFECTIVENESS; VISUAL INSPECTION; KENYA; INTEGRATION; INFECTION;
|
|
|
|
|
|
|
|
INDIA; CARE'
|
|
|
|
language: English
|
|
|
|
month: DEC
|
|
|
|
number: '5'
|
|
|
|
number-of-cited-references: '48'
|
|
|
|
pages: 39-43
|
|
|
|
papis_id: 83658330c46ffb293390fb56cefbcb43
|
|
|
|
ref: Huchko2015timehas
|
|
|
|
researcherid-numbers: Huchko, Megan/S-6063-2019
|
|
|
|
times-cited: '3'
|
|
|
|
title: The time has come to make cervical cancer prevention an essential part of comprehensive
|
|
|
|
sexual and reproductive health services for HIV-positive women in low-income countries
|
2023-10-01 08:15:07 +00:00
|
|
|
type: article
|
2023-09-28 14:46:10 +00:00
|
|
|
unique-id: WOS:000365969900006
|
|
|
|
usage-count-last-180-days: '0'
|
|
|
|
usage-count-since-2013: '11'
|
|
|
|
volume: '18'
|
|
|
|
web-of-science-categories: Immunology; Infectious Diseases
|
|
|
|
year: '2015'
|